Hagen B - Search Results

1

ESGO statement on cervical cancer vaccination.

Vergote I, van der Zee AG, Kesic V, Sert B, Robova H, Rob L, Reed N, Luesley DM, Leblanc E, Hagen B, Gitsch G, du Bois A, di Vagno G, Colombo N, Beller U, Ayhan A, Jacobs I. Vergote I, et al. Among authors: hagen b. Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1183-5. doi: 10.1111/j.1525-1438.2007.01129.x. Int J Gynecol Cancer. 2007. PMID: 17997794 No abstract available.

2

Parametrial resection for invasive cervical cancer.

Hagen B, Shepherd JH, Jacobs IJ. Hagen B, et al. Int J Gynecol Cancer. 2000 Jan;10(1):1-6. doi: 10.1046/j.1525-1438.2000.00014.x. Int J Gynecol Cancer. 2000. PMID: 11240644

3

Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass.

Hogdall EV, Høgdall CK, Tingulstad S, Hagen B, Nustad K, Xu FJ, Bast RC, Jacobs IJ. Hogdall EV, et al. Among authors: hagen b. Int J Cancer. 2000 Nov 20;89(6):519-23. Int J Cancer. 2000. PMID: 11102897

4

Cervical carcinoma: postoperative radiotherapy: fifteen-year experience in a Norwegian health region.

Lorenz E, Strickert T, Hagen B. Lorenz E, et al. Among authors: hagen b. Int J Gynecol Cancer. 2009 Dec;19(9):1595-9. doi: 10.1111/IGC.0b013e3181bed288. Int J Gynecol Cancer. 2009. PMID: 19955944

5

Ten years' experience with centralized surgery of ovarian cancer in one health region in Norway.

Aune G, Torp SH, Syversen U, Hagen B, Tingulstad S. Aune G, et al. Among authors: hagen b. Int J Gynecol Cancer. 2012 Feb;22(2):226-31. doi: 10.1097/IGC.0b013e31823589ef. Int J Gynecol Cancer. 2012. PMID: 22080889

6

Model for the molecular genetic diagnosis of endometrial cancer using K-ras mutation analysis.

Al-Jehani RM, Jeyarajah AR, Hagen B, Hogdall EV, Oram DH, Jacobs IJ. Al-Jehani RM, et al. Among authors: hagen b. J Natl Cancer Inst. 1998 Apr 1;90(7):540-2. doi: 10.1093/jnci/90.7.540. J Natl Cancer Inst. 1998. PMID: 9539251 No abstract available.

7

[Can human papillomavirus testing and vaccination prevent cervical cancer?].

Lie AK, Bjørge T, Helland A, Hagen B, Skjeldestad FE, Hagmar B, Thoresen S. Lie AK, et al. Among authors: hagen b. Tidsskr Nor Laegeforen. 2001 Oct 20;121(25):2947-51. Tidsskr Nor Laegeforen. 2001. PMID: 11715778 Review. Norwegian.

8

Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument.

Tropé C, Kaern J, Hogberg T, Abeler V, Hagen B, Kristensen G, Onsrud M, Pettersen E, Rosenberg P, Sandvei R, Sundfor K, Vergote I. Tropé C, et al. Among authors: hagen b. Ann Oncol. 2000 Mar;11(3):281-8. doi: 10.1023/a:1008399414923. Ann Oncol. 2000. PMID: 10811493 Free article. Clinical Trial.

9

A phase II study of biweekly administration of paclitaxel in patients with recurrent epithelial ovarian cancer.

Lorenz E, Hagen B, Himmelmann A, Kjørstad K, Onsrud M, Tingulstad S, Gundersen G. Lorenz E, et al. Among authors: hagen b. Int J Gynecol Cancer. 1999 Sep;9(5):373-376. doi: 10.1046/j.1525-1438.1999.99046.x. Int J Gynecol Cancer. 1999. PMID: 11240796

10

10-Gy single-fraction pelvic irradiation for palliation and life prolongation in patients with cancer of the cervix and corpus uteri.

Onsrud M, Hagen B, Strickert T. Onsrud M, et al. Among authors: hagen b. Gynecol Oncol. 2001 Jul;82(1):167-71. doi: 10.1006/gyno.2001.6233. Gynecol Oncol. 2001. PMID: 11426980

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters